Actively Recruiting
Evaluation of Plasma Renin Concentrations in Cardiac Surgery
Led by Mayo Clinic · Updated on 2026-05-13
100
Participants Needed
1
Research Sites
63 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this research is to learn more about how renin (a blood test) is affected by cardiopulmonary bypass, the heart-lung machine used during open heart surgery. Renin is a protein that may be elevated in response to low blood pressure or situations where organs do not receive sufficient oxygen. Renin may potentially be used as an indicator for specific treatments aimed to increase the blood pressure. This study will evaluate blood samples for renin concentration throughout the course of open heart surgery.
CONDITIONS
Official Title
Evaluation of Plasma Renin Concentrations in Cardiac Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult persons 18 years of age or greater.
- Scheduled for an elective cardiac surgical procedure involving the use of cardiopulmonary bypass.
You will not qualify if you...
- Surgery involving heart or lung transplantation or implant of a durable left ventricular assist device.
- Emergency cardiac surgery.
- Established diagnosis of any congenital heart disease.
- End-stage kidney disease receiving kidney replacement therapy before surgery.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
P
Patrick M Wieruszewski, Pharm.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here